how much does it cost to make a cryptocurrency Top

Xpeng Motors: Tucki P7+ completed the formal delivery of 10,000 Tucki P7+ sets within four weeks after listing.The wide currency and weak credit logic may continue, and the upward direction of the market volatility will not change. The Shanghai and Shenzhen 300ETF South (159925) is gaining momentum. On December 11, the Shanghai and Shenzhen 300ETF South (159925) closed down by 0.25%, with a turnover of 75,892,100 yuan. The constituent stocks are mixed. In terms of rising, Midea Group led the rise, and Changjiang Power followed suit. In terms of decline, China Ping An led the decline, while Contemporary Amperex Technology Co., Limited followed. In the news, Contemporary Amperex Technology Co., Limited, the power battery giant, once again announced that it will build a power battery factory overseas, which will also become the company's third battery factory in Europe. Bank of China Securities said that the important meeting at the end of the year is about to land, and the market may face fluctuations caused by the expected landing of policies in the short term, but the tone of monetary policy will not change. The logic of "wide money+weak credit" will continue in the short term. Under the expectation of loose monetary policy, the upward direction of market volatility will not change. According to industry insiders, looking forward to 2025, the allocation of A-share industry can be developed around three main lines: first, the direction of domestic macro-circulation, attaching importance to "duality and innovation", "debt conversion" and new growth points in the consumption field; Second, science and technology are self-reliant: pay attention to artificial intelligence industry, self-controllable, new energy technology, aerospace information technology and data elements; The third is to open wider to the outside world: pay attention to cross-border e-commerce, digital trade, tax exemption and inbound tourism. You can use the Shanghai and Shenzhen 300ETF South (159925) to lay out the core assets with one click.Market News: The Knesset group approved a bill to increase deficit ratio's GDP to 7.7%, which will be submitted to the Knesset plenary session for voting.

 European bond market: The market remained stable before the US inflation data was released, waiting for the ECB meeting on Thursday. On Wednesday, the European bond market remained stable, waiting for the US consumer price index (CPI) data later that day and the ECB meeting on Thursday. The yield of German 10-year government bonds did not change much, at 2.12%. Traders are waiting for the US CPI inflation data released at 21: 30 Beijing time on Wednesday, which may affect the market expectation that the Fed will cut interest rates next week. The yield of Italian 10-year government bonds also remained basically unchanged at 3.20%, and the spread between Italian government bonds and German government bonds remained at 108 basis points. The market expects the European Central Bank to cut interest rates by 25 basis points on Thursday. The yield of German two-year government bonds is sensitive to the interest rate expectations of the European Central Bank, falling by 1 basis point to 1.96%.Grant Thornton Group, a Hong Kong financial consulting and IPO sponsor service provider, is priced at $ 4-5 per share, and plans to raise $10 million.

Modern Pharmaceuticals: Sinopharm Zhijun, the holding subsidiary, obtained the drug registration certificate of Cefotaxime Tablets. Modern Pharmaceuticals announced that Sinopharm Zhijun Pharmaceutical Co., Ltd., the holding subsidiary, recently received the Drug Registration Certificate of Cefotaxime Tablets approved and issued by National Medical Products Administration. Cefopoxime axetil tablets are the third generation cephalosporins taken orally, which are used to treat upper respiratory tract infections and lower respiratory tract infections caused by sensitive bacteria. In 2023, the global sales of preparations will be USD 370 million, and the sales of public hospitals nationwide will be RMB 102 million. The accumulative R&D investment of Sinopharm Zhijun is about RMB 28.45 million. Obtaining the registration certificate will enrich the company's product line, increase market competitiveness and have a positive impact on the company's future development. However, drug sales are easily affected by factors such as policies and market environment, and there are uncertainties.On the 11th, the glass fell by 1.20%, and the latest main contract positions changed as follows. According to the exchange data, as of December 11th, the main contract glass 2501 closed, up or down by -1.20%, with a turnover of 365,200 lots. The position data showed that the top 20 seats were clear, and the difference position was 73,552 lots. The total turnover of glass futures contracts was 754,900 lots, a decrease of 1,229,700 lots from the previous day. The first 20 seats in the contract held 600,900 lots, an increase of 3,641 lots over the previous day. Short positions in the top 20 seats of the contract were 707,300 lots, an increase of 13,900 lots over the previous day. (Sina Futures)It is reported that Walgreens Boots Alliance is negotiating to sell itself to a private equity company, which will delist the drugstore chain. The company's share price has been declining for nearly ten years. According to informed sources, Wobolian and Sycamore Partners have been discussing a deal, which may be completed as early as early next year, provided that the negotiations do not break down. It is reported that the market value of Wobolian peaked at more than 100 billion US dollars in 2015, but it has shrunk to about 7.5 billion US dollars since then.